Cosmeceuticals Market to 2018 - Technological Advances and Consumer Awareness Boost Commercial Potential for Innovative and Premium-Priced Products
Publisher Name » GBI Research
Published Date » 2013-01-22
No. Of Pages » 39
Cosmeceuticals Market to 2018 Technological Advances and Consumer Awareness Boost Commercial Potential for Innovative and Premium-Priced Products
Summary
Leading business intelligence provider GBI Research has released its latest research report, entitled, Cosmeceuticals Market to 2018 Technological Advances and Consumer Awareness Boost Commercial Potential for Innovative and Premium-Priced Products. The report provides insights into the global cosmeceuticals market, which comprises the top seven developed markets: the US, the top five European countries (the UK, Germany, France, Italy and Spain) and Japan, with market forecasts until 2018. The report gives an overview of cosmeceuticals, covering the common ingredients used and important regulatory guidelines followed. It also analyses important market and industry trends that might drive the market in the future. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.
GBI Research found that the global cosmeceuticals market was estimated to be worth $30.9 billion in 2011, having grown at a Compound Annual Growth Rate (CAGR) of 3.6% from $24.1 billion in 2004. In 2011, the top five European countries accounted for almost 65% of the overall cosmeceuticals market, followed by the US. This is mainly driven by the obsession with maintaining a youthful appearance, better results of cosmeceuticals, heavy marketing, slow economic improvement, and rising per-capita disposable income.
Cosmeceutical brand growth is further driven by expanded markets in Asia-Pacific, digital marketing and the offer of personalized customer experiences and e-commerce. Demand is driven by the emergence of the urban middle class with increased incomes, affordability and urbanization who demand efficient products and luxury brands. Anti-oxidants remain one of the most popular ingredients for skin care and are now being included in other healthcare regimens for their perceived benefits to overall health.
Scope
- Annualized market data for the cosmeceuticals market from 2004 to 2011 and forecast to 2018
- Analysis of the cosmeceuticals market in the leading geographies of the world: the US, the UK, Germany, France, Italy, Spain, and Japan
- Analysis of the cosmeceuticals market by key category, including skin care and hair care
- SWOT analysis of the cosmeceuticals market industry
- Competitive benchmarking of leading companies: Beiersdorf, Colgate-Palmolive, Henkel, Johnson & Johnson, LOreal S.A., Procter & Gamble and Unilever
Reasons to buy
- Align your product portfolio to the markets with high growth potential
- Develop market-entry and market-expansion strategies by identifying the regions and market segments poised for strong growth
- Create a more tailored country strategy through the understanding of market outlook and major trends in cosmeceuticals industry.
- Develop key strategic initiatives by understanding the key focus areas and top-selling products of leading companies
Table of Contents
1 Table of Contents 5
1.1 List of Tables 6
1.2 List of Figures 6
2 Cosmeceuticals Market to 2018 - Introduction 7
3 Cosmeceuticals Market to 2018 - Overview 8
3.1 Introduction 8
3.1.1 Classification 8
3.2 Economic Trends 8
3.3 Common Ingredients in Cosmeceuticals 8
3.3.1 Retinoids 8
3.3.2 Hydroxy Acids 8
3.3.3 Antioxidants 9
3.3.4 De-pigmenting Agents 9
3.3.5 Botanicals 9
3.3.6 Enzymes 9
3.3.7 Hormones 10
3.3.8 Topical Anesthetics and Antipruritics 10
3.3.9 Hair-loss Treatments 11
3.3.10 Scar Treatments 11
3.4 Safety and Regulation 13
3.4.1 Coverage by the US Food and Drug Administration 13
3.4.2 Coverage by the US Federal Trade Commission 13
3.4.3 Coverage by the European Medicines Agency 13
3.4.4 Coverage by Ministry of Health, Labor and Welfare, Japan 14
3.4.5 Standards for Natural and Organic Products 14
3.5 Product Development and Application Technologies 15
3.1 Introduction 8
3.1.1 Classification 8
3.2 Economic Trends 8
3.3 Common Ingredients in Cosmeceuticals 8
3.3.1 Retinoids 8
3.3.2 Hydroxy Acids 8
3.3.3 Antioxidants 9
3.3.4 De-pigmenting Agents 9
3.3.5 Botanicals 9
3.3.6 Enzymes 9
3.3.7 Hormones 10
3.3.8 Topical Anesthetics and Antipruritics 10
3.3.9 Hair-loss Treatments 11
3.3.10 Scar Treatments 11
3.4 Safety and Regulation 13
3.4.1 Coverage by the US Food and Drug Administration 13
3.4.2 Coverage by the US Federal Trade Commission 13
3.4.3 Coverage by the European Medicines Agency 13
3.4.4 Coverage by Ministry of Health, Labor and Welfare, Japan 14
3.4.5 Standards for Natural and Organic Products 14
3.5 Product Development and Application Technologies 15
4 Cosmeceuticals Market to 2018 - Market Overview 16
4.1 Market Overview 16
4.2 Market by Geography 18
4.2.1 US 18
4.2.2 Top Five European Countries 19
4.2.3 Japan 20
4.3 Market by Channel 21
4.4 Market Trends 21
4.4.1 Demographic Trends 21
4.4.2 Cosmeceutical Treatments and Product Trends 23
4.4.3 Industry Trends 25
4.4.4 SWOT Analysis 26
4.1 Market Overview 16
4.2 Market by Geography 18
4.2.1 US 18
4.2.2 Top Five European Countries 19
4.2.3 Japan 20
4.3 Market by Channel 21
4.4 Market Trends 21
4.4.1 Demographic Trends 21
4.4.2 Cosmeceutical Treatments and Product Trends 23
4.4.3 Industry Trends 25
4.4.4 SWOT Analysis 26
5 Cosmeceuticals Market to 2018 - Market by Category 27
5.1 Skin Care Cosmeceuticals 28
5.1.1 Introduction 28
5.2 Hair Care Cosmeceuticals 28
5.2.1 Introduction 28
5.3 Cosmeceuticals Market Outlook 29
5.3.1 Cosmeceuticals and Premium Pricing 29
5.3.2 Consumer Perception 29
5.3.3 Cosmeceuticals - A Lucrative Opportunity for Pharmaceutical Companies? 30
5.3.4 Cosmeceuticals and Impact of Regulations 30
5.1 Skin Care Cosmeceuticals 28
5.1.1 Introduction 28
5.2 Hair Care Cosmeceuticals 28
5.2.1 Introduction 28
5.3 Cosmeceuticals Market Outlook 29
5.3.1 Cosmeceuticals and Premium Pricing 29
5.3.2 Consumer Perception 29
5.3.3 Cosmeceuticals - A Lucrative Opportunity for Pharmaceutical Companies? 30
5.3.4 Cosmeceuticals and Impact of Regulations 30
6 Cosmeceuticals Market to 2018 - Competitive Landscape 31
6.1 Company Profiles 31
6.1.1 Beiersdorf 31
6.1.2 Colgate-Palmolive 31
6.1.3 Henkel 32
6.1.4 Johnson & Johnson 33
6.1.5 L'Oreal S.A. 33
6.1.6 Procter & Gamble Company 34
6.1.7 Unilever 35
6.1 Company Profiles 31
6.1.1 Beiersdorf 31
6.1.2 Colgate-Palmolive 31
6.1.3 Henkel 32
6.1.4 Johnson & Johnson 33
6.1.5 L'Oreal S.A. 33
6.1.6 Procter & Gamble Company 34
6.1.7 Unilever 35
7 Cosmeceuticals Market to 2018 - Appendix 36
7.1 Market Definitions 36
7.2 Abbreviations 36
7.3 Bibliography 37
7.4 Research Methodology 37
7.4.1 Coverage 37
7.4.2 Secondary Research 38
7.4.3 Primary Research 38
7.4.4 Expert Panel Validation 38
7.5 Contact Us 39
7.6 Disclaimer 39
7.1 Market Definitions 36
7.2 Abbreviations 36
7.3 Bibliography 37
7.4 Research Methodology 37
7.4.1 Coverage 37
7.4.2 Secondary Research 38
7.4.3 Primary Research 38
7.4.4 Expert Panel Validation 38
7.5 Contact Us 39
7.6 Disclaimer 39
List of Tables
Table 1: Cosmeceuticals Market, Global, Revenue ($bn), 2004-2011 17
Table 2: Cosmeceuticals Market, Global, Revenue Forecast ($bn), 2011-2018 17
Table 3: Cosmeceuticals Market, US, Revenue ($bn), 2004-2011 18
Table 4: Cosmeceuticals Market, US, Revenue Forecast ($bn), 2011-2018 18
Table 5: Cosmeceuticals Market, Top Five European Countries, Revenue ($bn), 2004-2011 19
Table 6: Cosmeceuticals Market, Top Five European Countries, Revenue Forecast ($bn), 2011-2018 19
Table 7: Cosmeceuticals Market, Japan, Revenue ($m), 2004-2011 20
Table 8: Cosmeceuticals Market, Japan, Revenue Forecast ($m), 2011-2018 20
Table 9: Cosmeceuticals Market, Population by Five-Year Age Group, Both Sexes (%), 1950-2010 22
List of Figures
Figure 1: Cosmeceuticals Market, Spherical Crystallization Method, 2013 15
Figure 2: Cosmeceuticals Market, Global, Revenue Forecast ($bn), 2004-2018 17
Figure 3: Cosmeceuticals Market, US, Revenue Forecast ($bn), 2004-2018 18
Figure 4: Cosmeceuticals Market, Top Five European Countries, Revenue Forecast ($bn), 2004-2018 19
Figure 5: Cosmeceuticals Market, Japan, Revenue Forecast ($m), 2004-2018 20
Figure 6: Cosmeceuticals Market, Population by Five-Year Age Group, Both Sexes, More Developed Countries (%), 1950-2010 21
Figure 7: Cosmeceuticals Market, Population by Five-Year Age Group, Both Sexes, Less Developed Countries (%), 1950-2010 22
Figure 8: Cosmeceuticals Market, SWOT Analysis 26
Figure 9: Cosmeceuticals Market, Global, Revenue Split by Category ($bn), 2011 27
Upcoming Reports:
|
Regenerative Medicines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
By - Transparency Market Research
The global regenerative medicines market is forecasted to reach the market value of $1.4 billion over the year 2015 powered by increasing focus on stem cell research, aging baby boomers, greater usage of non-autograft products, and increasing investments in research and development activities.
Regenerative medicine industry is assumed to be the next generation technology to revolutionize the medical system in the upcoming years. This industry is still in growing stage in terms of commercial applications, with a number of available products being limited to the field of...
|
|
Cancer Profiling And Pathways Market - Global Industry Analysis, Market Size, Share, Growth, Trends, And Forecast, 2012 - 2018
By - Transparency Market Research
Cancer cells exhibit a fundamentally modified metabolism that creates an environment in the body to support the growth of tumors and malignancy. In-depth understanding of the biochemical characters of cancer has facilitated the understanding and implementation of several different cancer profiling platforms.
Deciphering the scope of altered metabolism of cancer cells, its relevance in disease pathogenesis, and its further potential in the discovery of suitable therapeutics, thus, demands development in technologies for the identification of modified enzymes and cellular...
|
|
Specialty Oilfield Chemical Market- Global And China Forecast, Market Share, Size, Growth And Industry Analysis (2010-2017)
By - Transparency Market Research
Specialty chemicals are sold on the basis of their performance rather than their chemical composition of single entity or complex composition. Intense knowledge is required to deliver products and services in the specialty chemicals segment. Due to which specialty chemical vendors produced higher sales volume and revenues in 2010 with an increase in the production cost as well. Major segments of specialty chemicals include specialty polymers, industrial and institutional cleaners, pesticides, electronic chemicals and construction chemicals altogether contributing 38% of the overall...
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Email: sales@researchmoz.us
Select License type:
Share this report
Latest Reports
- Bed Linen Markets in the World to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Eastern Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Western Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Asia to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Americas to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Africa to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in the Top 10 Global Countries to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in the Top 5 European Countries to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in the Top 5 Asian countries to 2017 - Market Size, Trends, and Forecasts
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|

